InvestorsHub Logo
Followers 78
Posts 24632
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 05/01/2024 9:12:13 AM

Wednesday, May 01, 2024 9:12:13 AM

Post# of 27550
PALI - 8.57/8.65 Up from 6.03

Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.